Restylane Lyft Receives FDA Nod for Enhancing the Chin Profile
The U.S. Food and Drug Administration (FDA) has approved Galderma’s Restylane Lyft with Lidocaine for augmentation of the chin region in patients aged 21 and up with mild-to-moderate chin retrusion. Restylane Lyft is also approved to treat the midface, facial folds and wrinkles (such as nasolabial folds), and back of hands. The filler, developed with […]